SEPTEMBERASIA BUSINESS OUTLOOK4 Vol 03 · Issue 04 - 8 · SEPTEMBER, 2024 Alok ChaturvediPublisherManaging EditorSudhakar SinghAssociate EditorDarshan KAssistant EditorKeerthana H KEditorial Team Roshan AktharNalini Bramhanapalli Viswanathan AManager - DesignPrabhu Dutta A.R.N RayEditorial queries editor@asiabusinessoutlook.comSales Team Vinson Raj Vandana S Shajilal Akshay Pratap Singh Shubham GroverTo subscribeVisit www.asiabusinessoutlook.com/subscribe/ or send emailto subscription@asiabusinessoutlook.comMagazine Price is $30 per issuePublisher Alok ChaturvediPrinted and Published By Alok Chaturvedi on behalf of Biz Print Media Pvt. Ltd. and Printed at Executive Prints - 113/7, Ground floor, Old madras road, Halasuru, Bangalore 560008 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Copyright © 2024 Biz Print Media Pvt. Ltd. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.Senior Designer Rajesh R BVisualizer Aruna Ksuanya chakrabortyGM Sales & Marketing Nagendra Kumar KCirculation Manager P MagendranAdvancing India's In-Vitro Diagnostics The market of In Vitro Diagnostics (IVD) in India has observed a phenomenal growth due to several factors such as rising health awareness, new generation IVD products, and the rising incidence of chronic diseases. Currently, the market has a CAGR of more than 10 percent owing to the expanding middle class, better healthcare facilities, and the increasing demand for point-of-care testing (POCT). The Indian IVD market is characterized by rapid adoption of advanced diagnostic technologies especially in the molecular diagnostics, immunoassays and clinical chemistry. The COVID-19 outbreak has galvanized this growth because of the focus on accurate and fast diagnosis, which has boosted investments in IVD technologies. Further, the government has also been instrumental in improving the diagnostic facilities in the country, especially in the rural and the urban sectors. An increase in NCDs such as diabetes, cardiovascular diseases, and cancer has also increased the need for early diagnosis and accurate tests to fuel the growth of the IVD market. Also, the rapid expansion of the digital health platforms and telemedicine has enhanced the diagnostics and thus fueling the market growth. However, there are still some issues, which are more related to the regulation and pricing issues. The current advancements in artificial intelligence (AI) and machine learning (ML) in diagnostics coupled with partnerships between local and global players are likely to counter these challenges.It is with the view of staying updated with the emerging trends in this market landscape that Asia Business Outlook has come up with a special issue containing stories of companies that have demonstrated their capability through their expertise. To strengthen this business landscape with their tightly-knit and result-oriented approach, they are setting new standards of effectiveness. Your input is valuable to us and we would appreciate your feedbacks and suggestions. Sudhakar SinghManaging Editoreditor@asiabusinessoutlook.com
< Page 3 | Page 5 >